glycopyrrolate has been researched along with Developmental Disabilities in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guzys, AT; Reddihough, DS; Reid, SM; Westbury, C | 1 |
| Colver, A; Fairhurst, C; Lodh, R; O'Hare, A; Parr, JR; Pennington, L; Steen, N; Weldon, E; Williams, J | 1 |
| Bachrach, SJ; Barker, T; Childs, J; Lakin, RC; Mier, RJ; Moran, M | 1 |
2 trial(s) available for glycopyrrolate and Developmental Disabilities
| Article | Year |
|---|---|
The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Topics: Adolescent; Child; Child, Preschool; Clinical Protocols; Developmental Disabilities; England; Glycopyrrolate; Humans; Muscarinic Antagonists; Nervous System Diseases; Patient Satisfaction; Research Design; Salivation; Scopolamine; Sialorrhea; Single-Blind Method; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2014 |
Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cross-Over Studies; Developmental Disabilities; Dose-Response Relationship, Drug; Double-Blind Method; Glycopyrrolate; Humans; Muscarinic Antagonists; Sialorrhea | 2000 |
1 other study(ies) available for glycopyrrolate and Developmental Disabilities
| Article | Year |
|---|---|
Anticholinergic medications for reducing drooling in children with developmental disability.
Topics: Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Developmental Disabilities; Female; Glycopyrrolate; Humans; Infant; Male; Scopolamine; Sialorrhea; Treatment Outcome; Trihexyphenidyl | 2020 |